Abnormal Gastroesophageal Flap Valve is Highly Associated with Endoscopic Reflux Esophagitis after Helicobacter pylori Eradication

Helicobacter

Volumn 9, Issue 1, 2004, Pages 1-8

  Takeuchi, Rie ^a   Kato, Kimitoshi ^a   Mizuno, Shigeaki ^a   Kawamura, Yo ^a   Kawamura, Fumio ^a   Iwasaki, Ariyoshi ^a   Arakawa, Yasuyuki ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHRONIC GASTRITIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE EXACERBATION; DISEASE SEVERITY; ENDOSCOPIC SURGERY; ERADICATION THERAPY; FEMALE; GASTRITIS; GASTROESOPHAGEAL FLAP VALVE; HELICOBACTER PYLORI; HUMAN; INCIDENCE; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PREDICTION; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; STATISTICAL SIGNIFICANCE; VALVE;

ADULT; CASE-CONTROL STUDIES; ESOPHAGITIS, PEPTIC; ESOPHAGOGASTRIC JUNCTION; ESOPHAGOSCOPY; ESOPHAGUS; FEMALE; GASTRIC MUCOSA; GASTRITIS; GASTROSCOPY; HELICOBACTER INFECTIONS; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER; RISK FACTORS;

HELICOBACTER PYLORI;

EID: 1342323935     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1083-4389.2004.00193.x     Document Type: Article

References (29)

1. Labenz J, Malfertheiner P. Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor? Gut 1997;41:277-80.
2. Labenz J, Blum AL, Bayerdorffer E, et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997;112:1442-7.
3. Shirota T, Kusano M, Kawamura O, et al. Helicobacter pylori infection correlates with severity of reflux esophagitis: with manometry findings. J Gastroenterol 1999;34:553-9.
4. Koike T, Ohara S, Sekine H, et al. Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut 2001;49:330-4.
5. Fallone CA, Barkun AN, Friedman G, et al. Is Helicobacter pylori eradication associated with gastroesophageal reflux disease? Am J Gastroenterol 2000;95:914-20.
6. Awad RA, Camacho S. Helicobacter pylori infection and hiatal hernia do not affect acid reflux and esophageal motility in patients with gastro-esophageal reflux. J Gastroenterol 2002;37:247-54.
7. Moayyedi P, Bardhan C, Young L, et al. Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology 2001;121:1120-6.
8. O'Connor HJ, McGee C, Ghabash NM, et al. Prevalence of esophagitis in H. pylori-positive peptic ulcer disease and the impact of eradication therapy. Hepatogastroenterol 2001;48:1064-8.
9. Schutze K, Hentschel E, Dragosics B, et al. Helicobacter pylori re-infection with identical organisms: transmission by the patients' spouses. Gut 1995;36:831-3.
10. Kahrilas PJ. Supraesophageal complications of reflux disease and hiatal hernia. Am J Med 2001;111:51S-55S.
11. Hill LD, Kozarek RA, Kraemer SJ, et al. The gastroesophageal flap valve: in vitro and in vivo observations. Gastrointest Endosc 1996;44:541-7.
12. Hill LD, Kozarek RA. The gastroesophageal flap valve. J Clin Gastroenterol 1999;28:194-7.
13. Contractor QQ, Akhtar SS, Contractor TQ. Endoscopic esophagitis and gastroesophageal flap valve. J Clin Gastroenterol 1999;28:233-7.
14. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969;1:87-97.
15. Kimura K, Satoh K, Ido K, et al. Gastritis in the Japanese stomach. Scand J Gastroenterol Suppl. 1996;214:17-20.
16. Koike T, Ohara S, Sekine H, et al. Increased gastric acid secretion after Helicobacter pylori eradication may be a factor for developing reflux oesophagitis. Aliment Pharmacol Ther 2001;15:813-20.
17. Rokkas T, Ladas SD, Liatsos C, et al. Effectiveness of acid suppression in preventing gastroesophageal reflux disease (GERD) after successful treatment of Helicobacter pylori infection. Dig Dis Sci 2001;46:1567-72.
18. Hamada H, Haruma K, Mihara M, et al. High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis. Aliment Pharmacol Ther 2000;14:729-35.
19. Haruma K, Hamada H, Mihara M, et al. Negative association between Helicobacter pylori infection and reflux esophagitis in older patients: case-control study in Japan. Helicobacter 2000;5:24-9.
20. Thor KB, Hill LD, Mercer DD, et al. Reappraisal of the flap valve mechanism in the gastroesophageal junction. A study of a new valvuloplasty procedure in cadavers. Acta Chir Scand 1987;153:25-8.
21. Paterson WG. The normal antireflux mechanism. Chest Surg Clin N Am 2001;11:473-83.
22. Hirsch DP, Holloway RH, Tytgat GN, et al. Involvement of nitric oxide in human transient lower esophageal sphincter relaxations and esophageal primary peristalsis. Gastroenterology 1998;115:1374-80.
23. DiBiase JK, Brand RE, Quigley EM. Endoluminal delivery of radiofrequency energy to the gastroesophageal junction in uncomplicated GERD. efficacy and potential mechanism of action. Am J Gastroenterol 2002;97:833-42.
24. Shiotani A, Yanaoka K, Iguchi M, et al. Helicobacter pylori infection reduces intraluminal nitric oxide in humans. J Gastroenterol 1999;34:668-74.
25. Azuma T, Ito Y, Suto H, et al. The effect of Helicobacter pylori eradication therapy on dyspepsia symptoms in industrial workers in Japan. Aliment Pharmacol Ther 2001;15:805-11.
26. Miwa H, Sugiyama Y, Ohkusa T, et al. Improvement of reflux symptoms 3 years after cure of Helicobacter pylori infection: a case-controlled study in the Japanese population. Helicobacter 2002;7:219-24.
27. Tucci A, Biasco G, Paparo GF. Effect of eradication of Helicobacter pylori in patients with fundic atrophic gastritis. N Engl J Med 1997;336:957-8.
28. Tucci A, Poli L, Biasco G, et al. Helicobacter pylori infection and gastric function in patients with fundic atrophic gastritis. Dig Dis Sci 2001;46:1573-83.
29. Haruma K, Mihara M, Okamoto E, et al. Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus-evaluation of 24-hour pH monitoring. Aliment Pharmacol Ther 1999;13:155-62.